New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
10:26 EDTUIS, TDG, SI, OHI, KIM, LLY, EV, BHI, PSUN, MXIM, JNJ, LNG, TPH, SLB, PFE, LVS, FNP, BLK, BMRN, BP, ATIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Allegheny Technologies (ATI) downgraded to Hold from Buy at Deutsche Bank... BP (BP) downgraded to Neutral from Outperform at Exane BNP Paribas... BioMarin (BMRN) downgraded to Equal Weight from Overweight at Barclays... BlackRock (BLK) downgraded to Neutral from Buy at Goldman... Cheniere Energy (LNG) downgraded to Neutral from Buy at Citigroup... Eli Lilly (LLY) downgraded to Underweight from Equal Weight at Barclays... Fifth & Pacific (FNP) downgraded to Hold from Buy at Brean Capital... Johnson & Johnson (JNJ) downgraded to Equal Weight from Overweight at Barclays... Kimco Realty (KIM) downgraded to Sell from Neutral at UBS... Las Vegas Sands (LVS) downgraded to Market Perform from Outperform at FBR Capital... Maxim Integrated (MXIM) downgraded to Perform from Outperform at Oppenheimer... Omega Healthcare (OHI) downgraded to Sell from Neutral at UBS... Pacific Sunwear (PSUN) downgraded to Neutral from Buy at Janney Capital... Pfizer (PFE) downgraded to Market Perform from Outperform at Cowen... Siemens (SI) downgraded to Neutral from Buy at BofA/Merrill... Schlumberger (SLB) downgraded to Sector Perform from Outperform at Iberia... Baker Hughes (BHI) downgraded to Sector Perform from Outperform at Iberia... TransDigm (TDG) downgraded to Neutral from Buy at DA Davidson... TRI Pointe Homes (TPH) downgraded to Market Perform from Outperform at FBR Capital... Eaton Vance (EV) downgraded at Susquehanna... Unisys (UIS) downgraded to Neutral from Positive at Susquehanna.
News For ATI;BP;BMRN;BLK;LNG;LLY;FNP;JNJ;KIM;LVS;MXIM;OHI;PFE;PSUN;SI;SLB;BHI;TDG;TPH;EV;UIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 >>
January 29, 2016
09:35 EDTLVSNevada reports Statewide December gaming win up 3.31% to $982.06M
The state also reports Las Vegas Strip December gaming win up 8.2% compared to last year at $600.75M compared to last year. Publicly traded companies in the space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).
07:36 EDTBPAnalysts still predicting mergers as oil slump drags on, WSJ reports
Bankers and analysts have been predicting a wave of merger activity will come almost since crude prices began to fall from over $100 a barrel, but the only big acquisition by an oil major so far has been Shell's (RDS.A) purchase of BG Group (BRGYY), said The Wall Street Journal, which added that analysts still believe deal-making is likely to return this year if prices continue to languish. With Chevron (CVX) set to report today and its big peers soon to follow, analysts are expecting the four biggest publicly traded Western oil companies to have their weakest combined profits since 1998, the Journal noted. The report noted that U.S. shale oil producers, such as Apache (APA) and Whiting Petroleum (WLL), were previously targeted though potential sellers were reluctant to accept offers as they hoped for a rebound in oil prices and potential buyers wondered if any deal struck would look expensive if crude prices fell further, but "both impediments are gone now," the Journal contends. Reference Link
05:39 EDTPFEPfizer: LIS awards infliximab biosimilar tender to Inflectra, Reuters reports
Pfizer says that the Norwegian Drug Procurement Cooperation has awarded its product Inflectra an infliximab biosimilar tender, Reuters reports. Reference Link
05:20 EDTLLYEli Lilly, Adocia initiate Phase 1b study of BioChaperone Lispro U100
Adocia and Eli Lilly announced the initiation of a Phase 1b clinical trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro licensed to Lilly. This formulation uses Adocia's proprietary technology, BioChaperone, which is designed to enable the acceleration of insulin absorption. The study, under the Adocia-Lilly partnership, aims to compare the pharmacokinetic and pharmacodynamic profiles of BioChaperone Lispro to that of Humalog in 15 healthy Japanese subjects placed under euglycemic clamp.
January 28, 2016
20:07 EDTBHISuperior Drilling to host business news update conference call
Business news update conference call to be held on January 29 at 9 am. Webcast Link
17:28 EDTUISUnisys sees FY16 revenue $2.775B-$2.875B, consensus $2.98B
Subscribe for More Information
16:38 EDTUISUnisys reports Q4 diluted EPS 2c, consensus 19c
Subscribe for More Information
16:22 EDTBHISuperior Drilling to supply Baker Hughes with Strider Drill System
Superior Drilling (SDPI) announced that it reached an agreement to supply the company's Strider Drill String Oscillation System and related services to Baker Hughes (BHI). The Strider utilizes its unique patent-pending design to reduce drill string friction on horizontal wells, resulting in improved rates of penetration and cost savings. Its revolutionary engineering provides a cost effective alternative to conventional downhole vibration tools.
10:55 EDTBPOPEC delegates say no plan for meeting Russia about production, Bloomberg says
Subscribe for More Information
10:13 EDTMXIMOptions with decreasing implied volatility
Subscribe for More Information
09:55 EDTLLYEli Lilly nears test of key support at $80 area
Subscribe for More Information
08:33 EDTLVSOptions expected to be active
Subscribe for More Information
08:18 EDTLVSLas Vegas Sands long-term risk/reward 'compelling,' says Stifel
Subscribe for More Information
08:06 EDTBHIBaker Hughes says 'fully dedicated' to closing merger as early as possible
Subscribe for More Information
08:05 EDTBHIBaker Hughes sees rig activity worldwide to continue to decline throughout 2016
Subscribe for More Information
08:04 EDTBHIBaker Hughes reports Q4 adjusted EPS (21c), consensus (10c)
Subscribe for More Information
07:39 EDTSLBCameron expects transaction with Schlumberger to close in 1Q16
06:29 EDTLLYEli Lilly backs FY16 adjusted EPS view of $3.45-$3.55, consensus $3.54
Backs FY16 revenue guidance of $20.2B-$20.7B, consensus $20.83B.
06:27 EDTLLYEli Lilly reports Q4 EPS 78c, consensus 78c
Reports Q4 revenue $5.38B, consensus $5.32B.
06:07 EDTBHIHalliburton upgraded to Buy from Accumulate at KLR Group
KLR Group analyst Darren Gacicia upgraded Halliburton (HAL) to Buy saying the risk/reward is favorable at current share levels. North America should be the first region to increase oil production activity in a recovery, and Halliburton has high exposure, Gacicia tells investors in a research note. Further, investor concerns related to the Baker Hughes (BHI) merger may present a positive catalyst for the shares whether the merger is completed or terminated, the analyst contends. He believes both companies remain motivated to complete the deal. Gacicia keeps a $44 price target for Halliburton shares. The oil services company closed yesterday up 12c to $29.06.
1 | 2 | 3 | 4 | 5 | 6 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use